Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01812278 · ClinicalTrials.gov registry record · NA
Randomized Trial of Web-Delivered Acceptance Therapy for Smoking Cessation (WebQuit)
A NA study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 2,637
- Enrollment target
NCT01812278: Completed NA study, sponsored by Fred Hutchinson Cancer Center.
NCT01812278 is a NA study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 2,637 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01812278, a NA study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,637 participants
- Enrollment target
Study Summary
The goal of this study is to determine whether the ACT website provides higher quit rates than a current standard smoking cessation website.
Primary Outcome
No smoking in the past 30 days, as reported 12 month post treatment.
Interventions
- BEHAVIORAL CBT
- BEHAVIORAL ACT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,637 participants |
| Start Date | 2014-03-24 |
| Est. Completion | 2019-12-31 |
| Phase | NA |
What the finished NCT01812278 record still lists
NCT01812278 is an interventional study that assigns participants to a tested intervention. Its 2,637 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% higher).
The record links to 0 conditions, and to 2 interventions - of which CBT is the first listed.
NCT01812278 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01812278 about?
NCT01812278 is a clinical study titled "Randomized Trial of Web-Delivered Acceptance Therapy for Smoking Cessation (WebQuit)". The goal of this study is to determine whether the ACT website provides higher quit rates than a current standard smoking cessation website.
What is the current status of trial NCT01812278?
This trial is currently completed. It is a NA study. The enrollment target is 2,637 participants. The study started on 2014-03-24. Estimated completion is 2019-12-31.
What interventions are being tested in trial NCT01812278?
The interventions under investigation include: CBT (BEHAVIORAL), ACT (BEHAVIORAL).
Who is sponsoring clinical trial NCT01812278?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01812278's enrollment target sits among peer trials
2,637 44th of 2000 higher than 1,957 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06455085 · 2,634 participants · NA
RESTORE: REducing Future fractureS and Improving ouTcOmes of fRagility fracturE
- NCT06825715 · 2,653 participants · NA
Multilevel Intervention for Precision Oncology
- NCT05471908 · 2,674 participants · NA
Follow-up Automatically vs. As-Needed Comparison (FAAN-C) Trial
- NCT06033950 · 2,600 participants · Phase 3
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI